Fortress Biotech Pref Preferred Stock Current Valuation
| FBIOP Preferred Stock | USD 5.12 0.15 2.85% |
Valuation analysis of Fortress Biotech Pref helps investors to measure Fortress Biotech's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Fortress Biotech's price fluctuation is slightly risky at this time. Calculation of the real value of Fortress Biotech Pref is based on 3 months time horizon. Increasing Fortress Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Fortress Biotech's intrinsic value may or may not be the same as its current market price of 5.12, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.12 | Real 5.47 | Hype 5.12 | Naive 5.35 |
The intrinsic value of Fortress Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fortress Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Fortress Biotech Pref helps investors to forecast how Fortress preferred stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fortress Biotech more accurately as focusing exclusively on Fortress Biotech's fundamentals will not take into account other important factors: Fortress Biotech Pref Company Current Valuation Analysis
Fortress Biotech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Fortress Biotech Current Valuation | 2.58 B |
Most of Fortress Biotech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fortress Biotech Pref is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Fortress Biotech Pref has a Current Valuation of 2.58 B. This is 82.03% lower than that of the Biotechnology sector and 44.45% lower than that of the Health Care industry. The current valuation for all United States preferred stocks is 84.48% higher than that of the company.
Fortress Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fortress Biotech's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the preferred stocks which would be a good addition to a portfolio. Peer analysis of Fortress Biotech could also be used in its relative valuation, which is a method of valuing Fortress Biotech by comparing valuation metrics of similar companies.Fortress Biotech is currently under evaluation in current valuation category among its peers.
Fortress Biotech ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Fortress Biotech's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Fortress Biotech's managers, analysts, and investors.Environmental | Governance | Social |
Fortress Fundamentals
| Return On Equity | -1.43 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (1.17) % | ||||
| Operating Margin | (2.63) % | ||||
| Current Valuation | 2.58 B | ||||
| Shares Outstanding | 56.68 M | ||||
| Shares Owned By Institutions | 1.80 % | ||||
| Number Of Shares Shorted | 245 | ||||
| Price To Sales | 1.36 X | ||||
| Revenue | 68.79 M | ||||
| Gross Profit | (85.66 M) | ||||
| EBITDA | (46.05 M) | ||||
| Net Income | (164.83 M) | ||||
| Cash And Equivalents | 248.77 M | ||||
| Cash Per Share | 2.31 X | ||||
| Total Debt | 46.56 M | ||||
| Debt To Equity | 0.81 % | ||||
| Current Ratio | 2.85 X | ||||
| Book Value Per Share | 0.57 X | ||||
| Cash Flow From Operations | (116.54 M) | ||||
| Short Ratio | 0.02 X | ||||
| Earnings Per Share | (0.86) X | ||||
| Number Of Employees | 173 | ||||
| Beta | 1.9 | ||||
| Market Capitalization | 107.79 M | ||||
| Total Asset | 396.5 M | ||||
| Z Score | 1.2 | ||||
| Annual Yield | 0.12 % | ||||
| Net Asset | 396.5 M |
About Fortress Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fortress Biotech Pref's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fortress Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fortress Biotech Pref based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for Fortress Preferred Stock Analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.